Sponsored Symposium Programme

Wednesday, 14 May 2025, 13:00 – 14:00 CEST

Life Uninterrupted – Advancing the Management of Vasomotor Symptoms Associated with Menopause

Auditorium 1

Highlight the unmet needs among women experiencing vasomotor symptoms (VMS) associated with menopause.
Present the 30-year journey leading to the development of VEOZA.
Showcase key clinical trial data and the impact of VEOZA on patients’ quality of life.

 

Chairman:

Prof. Pluvio Coronado Martin | Complutense University of Madrid, Spain

Speakers: 

  • Dr. Pauline Maki | University of Illinois at Chicago College of Medicine, USA
  • Prof. Petra Stute | University Hospital of Bern, Switzerland

Wednesday, 14 May 2025, 14:15 – 15:15 CEST

Facing Needs and Fears in Menopause

Auditorium 2

  • Objective: Unmet needs in menopause (surveys’ insights) – Rossella Nappi (IT)
  • Pannel discussion: Critical appraisal of guidelines in menopause. The potential of E2 transdermal to fill the gap: Rossella Nappi (IT),  Tommaso Simoncini (IT),  Paula Briggs (UK)
  • Lenzetto profile & real world data – Angelica Linden-Hirshberg (SW)

 

Chairman: 

Tommaso Simoncini (IT)

Thursday, 15 May 2025, 08:30 – 09:30 CEST

Clinical Conversations – Perspectives on the Management of Vasomotor Symptoms Associated with Menopause

Auditorium 2

Discuss the current treatment landscape for VMS.
Establish VEOZA as a first-line nonhormonal treatment for moderate to severe VMS.
Address clinical implementation considerations for VEOZA

 

Chairman: 

Prof. Rosella Nappi | University of Pavia, Italy

Speaker: 

Prof. Petra Stute | University Hospital of Bern, Switzerland
Speaker: Dr. Vikram Talaulikar | University College Hospitals NHS Foundation Trust, London, UK

 

Thursday, 15 May 2025, 12:30 – 14:00 CEST

The importance of individualising Menopausal Hormone Therapy (MHT) and its impact on women’s long-term health

Auditorium 1

The aim of the symposium is to explore the importance of individualized menopausal hormone therapy (MHT) and its impact on cardiovascular health in postmenopausal women. A key focus will be the role of different progestogens in MHT, with an emphasis on their differentiation and clinical considerations. 

 

Speakers: 

  • Prof. Antonio Cano: Department of Paediatrics, Obstetrics & Gynaecology University of Valencia, Valencia, Spain
  • Prof. Petra Stute: Department of Gynaecological Endocrinology & Reproductive Medicine University Hospital of Bern, Switzerland
  • Prof. Marco Gambacciani: Clinica San Rossore, Pisa, Italy
  • Prof. Nick Panay: Department of Metabolism, Digestion & Reproduction Imperial College London, UK

 

Thursday, 15 May 2025, 18:00 – 18:45 CEST

Weight Management in Menopause: Improving Health, Quality of Life and Cardiovascular Risk

Auditorium 3

Objective:

  • This symposium will explore the relationship between excess weight, menopause, and women’s health, specifically highlighting its critical implications for cardiovascular health.
  • Through comprehensive data, we will examine how weight influences quality of life and overall well-being of women in menopause.
  • We will emphasize the importance of effective obesity management, addressing the need for targeted interventions.
  • The expert panel will share insights into evidence-based treatment strategies and practical clinical solutions aimed at improving the health of women with excess weight navigating menopause, particularly focusing on the role of antiobesity medications.
  • What guidelines support their use, and how can we improve the management of overweight and obesity during this life stage?
  • Don’t miss this opportunity to advance your knowledge of weight management, menopause, and cardiovascular health, and to explore effective solutions to optimize outcomes for menopausal women.

 

Speakers: 

  • Chair: Dr. Santiago Palacios
  • Speaker: Dr. Rossella Nappi
  • Speaker: Dr. Katrin Schaudig
  • Speaker: Dr. Rodrigo Orozco

 

Friday, 16 May 2025, 12:30 – 13:30 CEST

VA/GSM and Lichen Sclerosus: Clinical Best Practice and Evidence for new therapies

Auditorium 2

 

The symposium explores the latest clinical practices and innovations in treating Lichen Sclerosus and Vaginal Atrophy Genitourinary (GSM). It includes discussions on recent clinical trials, patient-centered care, and the integration of new therapies like StrataMGT into treatment protocols, aiming to enhance patient outcomes in these specialised fields.